BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8015549)

  • 1. Deletion of residues 485-599 from the human insulin receptor abolishes antireceptor antibody binding and influences tyrosine kinase activation.
    Sung CK; Wong KY; Yip CC; Hawley DM; Goldfine ID
    Mol Endocrinol; 1994 Mar; 8(3):315-24. PubMed ID: 8015549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody to the human insulin receptor, but not insulin, stimulates S6 kinase via human insulin receptors mutated at three major tyrosine autophosphorylation sites.
    Sung CK
    J Cell Biochem; 1992 Mar; 48(3):324-35. PubMed ID: 1328257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies mimic insulin activation of ribosomal protein S6 kinase without activation of insulin receptor tyrosine kinase. Studies in cells transfected with normal and mutant human insulin receptors.
    Sung CK; Maddux BA; Hawley DM; Goldfine ID
    J Biol Chem; 1989 Nov; 264(32):18951-9. PubMed ID: 2553727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-linked oligosaccharide chains of the insulin receptor beta subunit are essential for transmembrane signaling.
    Leconte I; Auzan C; Debant A; Rossi B; Clauser E
    J Biol Chem; 1992 Aug; 267(24):17415-23. PubMed ID: 1324936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of biological functions by an insulin receptor monoclonal antibody in insulin receptor beta-subunit mutants.
    Sung CK; Han XL; Brunetti A; Maddux B; Yamamoto-Honda R; Goldfine ID
    Biochemistry; 1992 Jan; 31(1):168-74. PubMed ID: 1731870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Replacement of the conserved tyrosine 1210 by phenylalanine in the insulin receptor affects insulin-induced dephosphorylation of focal adhesion kinase but leaves other responses intact.
    Van der Zon GC; Ouwens DM; Dorrestijn J; Maassen JA
    Biochemistry; 1996 Aug; 35(32):10377-82. PubMed ID: 8756693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen).
    Band CJ; Posner BI; Dumas V; Contreres JO
    Mol Endocrinol; 1997 Dec; 11(13):1899-910. PubMed ID: 9415395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to the insulin receptor (B-10) can stimulate tyrosine phosphorylation of the beta-subunit of the insulin receptor and a 185,000 molecular weight protein in rat hepatoma cells.
    Takayama-Hasumi S; Tobe K; Momomura K; Koshio O; Tashiro-Hashimoto Y; Akanuma Y; Hirata Y; Takaku F; Kasuga M
    J Clin Endocrinol Metab; 1989 Apr; 68(4):787-95. PubMed ID: 2466044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin receptor monoclonal antibodies that mimic insulin action without activating tyrosine kinase.
    Hawley DM; Maddux BA; Patel RG; Wong KY; Mamula PW; Firestone GL; Brunetti A; Verspohl E; Goldfine ID
    J Biol Chem; 1989 Feb; 264(5):2438-44. PubMed ID: 2536710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenic and mitogenic capacities are reduced in transfected fibroblasts expressing mutant insulin-like growth factor (IGF)-I receptors. The role of tyrosine residues 1250, 1251, and 1316 in the carboxy-terminus of the IGF-I receptor.
    Blakesley VA; Kalebic T; Helman LJ; Stannard B; Faria TN; Roberts CT; LeRoith D
    Endocrinology; 1996 Feb; 137(2):410-7. PubMed ID: 8593783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the insulin receptor beta-subunit acidic domain results in enhanced metabolic signaling.
    Rolband GC; Williams JF; Webster NJ; Olefsky JM
    Endocrinology; 1993 Sep; 133(3):1437-43. PubMed ID: 8396020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nature and regulation of the insulin receptor: structure and function.
    Czech MP
    Annu Rev Physiol; 1985; 47():357-81. PubMed ID: 2986534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmembrane signalling by insulin via an insulin receptor mutated at tyrosines 1158, 1162, and 1163.
    Rafaeloff R; Maddux BA; Brunetti A; Sbraccia P; Sung CK; Patel R; Hawley DM; Goldfine ID
    Biochem Biophys Res Commun; 1991 Sep; 179(2):912-8. PubMed ID: 1898412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to insulin receptor tyrosine kinase stimulate its activity towards exogenous substrates without inducing receptor autophosphorylation.
    Baron V; Gautier N; Rochet N; Ballotti R; Rossi B; Saint-Pierre S; Van Obberghen E; Dolais-Kitabgi J
    Biochem J; 1989 Jun; 260(3):749-56. PubMed ID: 2764902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diabetes and sex steroid hormones on insulin receptor tyrosine kinase activity in R3230AC mammary adenocarcinomas.
    Hilf R; Livingston JN; Crofton DH
    Cancer Res; 1988 Jul; 48(13):3742-50. PubMed ID: 3288334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A domain of the insulin receptor required for endocytosis in rat fibroblasts.
    Thies RS; Webster NJ; McClain DA
    J Biol Chem; 1990 Jun; 265(17):10132-7. PubMed ID: 2161833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation of the high cysteine region of the human insulin receptor alpha-subunit increases insulin receptor binding affinity and transmembrane signaling.
    Rafaeloff R; Patel R; Yip C; Goldfine ID; Hawley DM
    J Biol Chem; 1989 Sep; 264(27):15900-4. PubMed ID: 2550426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin action is mimicked by polyclonal antireceptor antibodies that activate the insulin receptor tyrosine kinase.
    Caron M; Cherqui G; Melin B; Wicek D; Capeau J; Picard J
    Horm Metab Res; 1989 Jun; 21(6):295-300. PubMed ID: 2550343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine-kinase defect of the insulin receptor in cultured fibroblasts from patients with lipoatropic diabetes.
    Magré J; Grigorescu F; Reynet C; Caron M; Capony JP; White MF; Picard J; Mirouze J; Capeau J
    J Clin Endocrinol Metab; 1989 Jul; 69(1):142-50. PubMed ID: 2543688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion of V335 from the L2 domain of the insulin receptor results in a conformationally abnormal receptor that is unable to bind insulin and causes Donohue's syndrome in a human subject.
    George S; Johansen A; Soos MA; Mortensen H; Gammeltoft S; Saudek V; Siddle K; Hansen L; O'Rahilly S
    Endocrinology; 2003 Feb; 144(2):631-7. PubMed ID: 12538626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.